Johan Mesterton

428 total citations
25 papers, 317 citations indexed

About

Johan Mesterton is a scholar working on Economics and Econometrics, Genetics and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Johan Mesterton has authored 25 papers receiving a total of 317 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Economics and Econometrics, 5 papers in Genetics and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Johan Mesterton's work include Health Systems, Economic Evaluations, Quality of Life (5 papers), Blood Pressure and Hypertension Studies (4 papers) and Healthcare Policy and Management (4 papers). Johan Mesterton is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (5 papers), Blood Pressure and Hypertension Studies (4 papers) and Healthcare Policy and Management (4 papers). Johan Mesterton collaborates with scholars based in Sweden, United States and Switzerland. Johan Mesterton's co-authors include Linus Jönsson, Anders Wimo, Sven Langworth, Bengt Winblad, Isis Amer‐Wåhlin, Peter Lindgren, Lars Ladfors, Jonas Banefelt, Patrik Sobocki and Kathleen M. Fox and has published in prestigious journals such as Journal of Clinical Oncology, Inflammatory Bowel Diseases and BMC Health Services Research.

In The Last Decade

Johan Mesterton

24 papers receiving 311 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Johan Mesterton Sweden 10 93 90 61 51 47 25 317
Gamal Saadi Egypt 11 83 0.9× 49 0.5× 32 0.5× 55 1.1× 45 1.0× 72 501
Art Zbrozek United States 12 122 1.3× 112 1.2× 137 2.2× 34 0.7× 54 1.1× 18 481
Robert Offer Canada 6 74 0.8× 211 2.3× 33 0.5× 60 1.2× 64 1.4× 6 582
Harry Verkleij Netherlands 10 162 1.7× 85 0.9× 39 0.6× 23 0.5× 43 0.9× 28 484
Aniela Angelow Germany 8 86 0.9× 42 0.5× 58 1.0× 26 0.5× 34 0.7× 24 281
Naleen Raj Bhandari United States 11 56 0.6× 42 0.5× 20 0.3× 71 1.4× 42 0.9× 52 472
S. Wahler Germany 8 45 0.5× 73 0.8× 26 0.4× 27 0.5× 54 1.1× 21 303
Borja García‐Lorenzo Spain 9 159 1.7× 237 2.6× 35 0.6× 45 0.9× 50 1.1× 16 465
Alice Heaney United Kingdom 10 36 0.4× 81 0.9× 41 0.7× 72 1.4× 29 0.6× 27 317
Theresa Coles United States 11 67 0.7× 43 0.5× 27 0.4× 67 1.3× 58 1.2× 52 379

Countries citing papers authored by Johan Mesterton

Since Specialization
Citations

This map shows the geographic impact of Johan Mesterton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Johan Mesterton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Johan Mesterton more than expected).

Fields of papers citing papers by Johan Mesterton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Johan Mesterton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Johan Mesterton. The network helps show where Johan Mesterton may publish in the future.

Co-authorship network of co-authors of Johan Mesterton

This figure shows the co-authorship network connecting the top 25 collaborators of Johan Mesterton. A scholar is included among the top collaborators of Johan Mesterton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Johan Mesterton. Johan Mesterton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mesterton, Johan, et al.. (2025). Healthcare Burden and Productivity Loss Due to Narcolepsy in Sweden. Clocks & Sleep. 7(1). 8–8.
2.
Fritzell, Peter, Johan Mesterton, & Olle Hägg. (2021). Prediction of outcome after spinal surgery—using The Dialogue Support based on the Swedish national quality register. European Spine Journal. 31(4). 889–900. 8 indexed citations
3.
4.
5.
Bergqvist, Jenny, Hanna Iderberg, Johan Mesterton, & Roger Henriksson. (2018). The effects of clinical and sociodemographic factors on survival, resource use and lead times in patients with high-grade gliomas: a population-based register study. Journal of Neuro-Oncology. 139(3). 599–608. 9 indexed citations
6.
7.
Banefelt, Jonas, et al.. (2016). Lipid‐lowering treatment patterns in patients with new cardiovascular events – estimates from population‐based register data in Sweden. International Journal of Clinical Practice. 70(3). 222–228. 1 indexed citations
8.
Mesterton, Johan, et al.. (2016). Case mix adjustment of health outcomes, resource use and process indicators in childbirth care: a register-based study. BMC Pregnancy and Childbirth. 16(1). 125–125. 17 indexed citations
9.
Ladfors, Lars, et al.. (2016). Case mix adjusted variation in cesarean section rate in Sweden. European Journal of Obstetrics & Gynecology and Reproductive Biology. 206. e161–e161. 4 indexed citations
10.
Banefelt, Jonas, Kathleen M. Fox, Johan Mesterton, et al.. (2015). Work productivity loss and indirect costs associated with new cardiovascular events in high-risk patients with hyperlipidemia: estimates from population-based register data in Sweden. The European Journal of Health Economics. 17(9). 1117–1124. 25 indexed citations
11.
Banefelt, Jonas, Kathleen M. Fox, Johan Mesterton, et al.. (2014). Work Productivity Loss and Indirect Costs Associated with New Cardiovascular Events in High-Risk Patients with Hyperlipidemia - Estimates from Population-Based Register Data in Sweden. Value in Health. 17(7). A327–A328. 1 indexed citations
12.
Banefelt, Jonas, Alexander Liede, Johan Mesterton, et al.. (2014). Survival and clinical metastases among prostate cancer patients treated with androgen deprivation therapy in Sweden. Cancer Epidemiology. 38(4). 442–447. 8 indexed citations
13.
Banefelt, Jonas, Johan Mesterton, Kathleen M. Fox, et al.. (2014). Health Care Costs Associated With Cardiovascular Events In Patients With Hyperlipidemia - Estimates From Population-Based Register Data In Sweden. Value in Health. 17(7). A492–A492. 1 indexed citations
14.
Salaj, Peter, Petr Cetkovský, Miroslav Penka, et al.. (2013). Economic evaluation of rFVIIa high initial dose compared to rFVIIa standard initial dose in patients with haemophilia with inhibitors using the Czech HemoRec registry. Thrombosis Research. 133(2). 162–167. 5 indexed citations
15.
Hernandez, Rohini K., Johan Mesterton, Jonas Banefelt, et al.. (2013). Predictors of clinical metastases and survival among nonmetastatic prostate cancer (PC) patients (pts) treated with androgen-deprivation therapy (ADT) in Sweden.. Journal of Clinical Oncology. 31(15_suppl). e16066–e16066. 1 indexed citations
16.
17.
Ólafsson, Gylfi, et al.. (2012). PSU25 Balloon Kyphoplasty Increases Quality of Life in Cancer Patients With Vertebral Compression Fractures. Value in Health. 15(7). A406–A406. 1 indexed citations
18.
Mesterton, Johan, et al.. (2010). Cross Sectional Observational Study on the Societal Costs of Alzheimers Disease. Current Alzheimer Research. 7(4). 358–367. 85 indexed citations
19.
Kavaklı, Kaan, Akif Yeşilipek, Salih Aksu, et al.. (2010). The value of early treatment in patients with haemophilia and inhibitors. Haemophilia. 16(3). 487–494. 23 indexed citations
20.
Mesterton, Johan, Linus Jönsson, Sven Almér, et al.. (2009). Resource use and societal costs for Crohnʼs disease in Sweden. Inflammatory Bowel Diseases. 15(12). 1882–1890. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gamal Saadi Breakdown of academic impact, for papers by Art Zbrozek Breakdown of academic impact, for papers by Robert Offer Breakdown of academic impact, for papers by Harry Verkleij Breakdown of academic impact, for papers by Aniela Angelow Breakdown of academic impact, for papers by Naleen Raj Bhandari Breakdown of academic impact, for papers by S. Wahler Breakdown of academic impact, for papers by Borja García‐Lorenzo Breakdown of academic impact, for papers by Alice Heaney Breakdown of academic impact, for papers by Theresa Coles
Rankless by CCL
2026